Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Predictive Oncology Inc. - Common Stock
(NQ:
POAI
)
5.950
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Predictive Oncology Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
July 26, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Why Is Predictive Oncology (POAI) Stock Up 70% Today?
↗
July 25, 2024
Predictive Oncology’s AI-driven platform demonstrated predictive utility in oncology, thereby providing credibility to POAI stock.
Via
InvestorPlace
Why Predicitive Oncology Stock Is Soaring
↗
July 25, 2024
Predictive Oncology shares are blasting higher Thursday after the company announced it is expanding its AI and machine learning driven drug discovery platform to pursue discovery of novel biomarkers....
Via
Benzinga
Topics
Artificial Intelligence
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
↗
July 25, 2024
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 25, 2024
Via
Benzinga
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
↗
July 25, 2024
Via
Benzinga
Topics
Stocks
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
July 25, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
July 25, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
↗
June 28, 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Via
InvestorPlace
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
June 11, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
June 11, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
June 04, 2024
Via
Investor Brand Network
Topics
Animal Testing
Artificial Intelligence
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
June 04, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024
May 29, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
May 29, 2024
Via
Benzinga
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
↗
May 29, 2024
Via
Benzinga
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
May 29, 2024
Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners...
From
Predictive Oncology Inc.
Via
GlobeNewswire
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 28, 2024
Via
Benzinga
Why Predictive Oncology (POAI) Stock Is Skyrocketing
↗
May 28, 2024
Predictive Oncology shares are trading higher by 46.6% during Tuesday's session. The company announced positive results from a retrospective study conducted with UPMC Magee-Womens Hospital.
Via
Benzinga
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Positive Results from Ovarian Cancer Study
May 28, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 28, 2024
Via
Benzinga
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone
From
Predictive Oncology Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Q1 2024 Financial Results, Provides Business Update
May 15, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
POAI Stock Earnings: Predictive Oncology Reported Results for Q1 2024
↗
May 15, 2024
Predictive Oncology just reported results for the first quarter of 2024.
Via
InvestorPlace
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024
Company to host investor call and webcast today, May 15th, at 8:30am EDT
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q1 2024 Financial Results, Conference Call
May 10, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
May 10, 2024
Management to host conference call and webcast at 8:30am ET
From
Predictive Oncology Inc.
Via
GlobeNewswire
The 3 Most Undervalued AI Penny Stocks to Buy in May 2024
↗
May 08, 2024
As the economy steadies, undervalued AI penny stocks represent a speculative yet promising frontier for risk-taking investors.
Via
InvestorPlace
Topics
Artificial Intelligence
Economy
AI-Fueled Penny Stocks: 3 High-Risk, High-Reward Opportunities
↗
May 08, 2024
AI penny stocks require an appetite for risk that offers the chance at outsized returns that are difficult to find elsewhere.
Via
InvestorPlace
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.